Breast Cancer

Latest News

Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy
Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy

July 23rd 2024

An expert explores the complexities of immunotherapy during pregnancy, highlighting risks to the fetus and the crucial role of oncology nurses in patient education and management.

ASCO Updates Guidance on CDK4/6 Inhibitors in Adjuvant Setting for HR+, HER2- Early Breast Cancer
ASCO Updates Guidance on CDK4/6 Inhibitors in Adjuvant Setting for HR+, HER2- Early Breast Cancer

July 19th 2024

Tailoring Second-Line Treatments for HR-Positive, HER2-Negative Metastatic Breast Cancer
Tailoring Second-Line Treatments for HR-Positive, HER2-Negative Metastatic Breast Cancer

July 11th 2024

A Journey Shared: Navigating Cancer as a Caretaker, Nurse, and Patient
A Journey Shared: Navigating Cancer as a Caretaker, Nurse, and Patient

July 9th 2024

Assisted Reproductive Techniques May Be Safe in BRCA-Mutated Breast Cancer
Assisted Reproductive Techniques May Be Safe in BRCA-Mutated Breast Cancer

July 5th 2024

Latest CME Events & Activities

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.